MannKind Corp. (MNKD)

[Phaeton]

The shares are not necessarily going to be issued.

These will be treasury shares which the company can use to use for a buy in or a buyout situation.

They could make a Another special offering just like they did in October for $61 million.

Having been engaged with this company since April 2014 my view is this is a good and bullish move by the board of directors/management team

You can look at several other companies that have done similar things in the last five years and they have all worked out well. One of those companies is named Exact Sciences.
They started TV advertising March of 2016.
The upward trajectory has been almost straight up since they started advertising.

MannKind Will follow the same pathway towards rising PPS. Many other Pharma companies have seen this same progress after begetting television advertising.

I can support them adding the additional shares as the company needs the flexibility to create international partnerships from a Pharma that wants to buy into selling
Afrezza somewhere else in the world.